StockDriftsStockDriftsTop 8 Takeda Pharmaceutical Co Ltd Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics, Inc. | 59.82% | 7.53M | $9.8M | +0.00%(+0) | $3.43(-48.14%) | 2025-09-30 | |
| EQ | Equillium, Inc. | 15.94% | 1.82M | $2.6M | +0.00%(+0) | $0.58(+158.30%) | 2025-09-30 | |
| XLO | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 7.59% | 1.48M | $1.2M | +0.00%(+0) | $0.92(-27.93%) | 2025-09-30 | |
| STTK | Shattuck Labs, Inc. | 7.53% | 515.6K | $1.2M | +0.00%(+0) | $5.22(-35.78%) | 2025-09-30 | |
| LYEL | Lyell Immunopharma, Inc. | 5.45% | 54.9K | $891K | +33.33%(+13.72K) | $17.32(+102.55%) | 2025-09-30 | |
| AMWL | American Well Corporation | 2.92% | 77.7K | $478K | +0.00%(+0) | $25.27(-82.00%) | 2025-09-30 | |
| RANI | Rani Therapeutics Holdings, Inc. | 0.62% | 203.2K | $102K | +0.00%(+0) | $2.62(-46.57%) | 2025-09-30 | |
| LAB | Standard Biotools, Inc. | 0.13% | 16.5K | $21K | +0.00%(+0) | $2.09(-33.83%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | -5.32% | -9.12% |
| Top 20 Holdings Unweighted | +3.35% | +5.93% |
Sign up free to track Takeda Pharmaceutical Co Ltd, compare funds side by side, and get alerts the moment positions change.